Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshihiro Matsushita is active.

Publication


Featured researches published by Yoshihiro Matsushita.


Tetrahedron Letters | 1986

An efficient synthesis of a key intermediate for optically active 5,6-cis-carbapenem antibiotics

Norikazu Tamura; Yasuhiko Kawano; Yoshihiro Matsushita; Kouichi Yoshioka; Michihiko Ochiai

Abstract A versatile intermediate (18) for optically active 5,6- cis -carbapenem antibiotics was synthesized with a highly regioselective intramolecular aldol condensation as a key step.


Bioorganic & Medicinal Chemistry Letters | 2013

Structure-based discovery of cellular-active allosteric inhibitors of FAK.

Naoki Tomita; Yoko Hayashi; Shinkichi Suzuki; Yoshimasa Oomori; Yoshio Aramaki; Yoshihiro Matsushita; Misa Iwatani; Hidehisa Iwata; Atsutoshi Okabe; Yoshiko Awazu; Osamu Isono; Robert J. Skene; David J. Hosfield; Hiroshi Miki; Tomohiro Kawamoto; Akira Hori; Atsuo Baba

In order to develop potent and selective focal adhesion kinase (FAK) inhibitors, synthetic studies on pyrazolo[4,3-c][2,1]benzothiazines targeted for the FAK allosteric site were carried out. Based on the X-ray structural analysis of the co-crystal of the lead compound, 8-(4-ethylphenyl)-5-methyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazine 4,4-dioxide 1 with FAK, we designed and prepared 1,5-dimethyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazin derivatives which selectively inhibited kinase activity of FAK without affecting seven other kinases. The optimized compound, N-(4-tert-butylbenzyl)-1,5-dimethyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazin-8-amine 4,4-dioxide 30 possessed significant FAK kinase inhibitory activities both in cell-free (IC50=0.64μM) and in cellular assays (IC50=7.1μM). These results clearly demonstrated a potential of FAK allosteric inhibitors as antitumor agents.


Tetrahedron | 1988

Synthesis of lactivicin analogues

Norikazu Tamura; Yoshihiro Matsushita; Kouichi Yoshioka; Michihiko Ochiai

Abstract Aza analogues of lactivicin (1), a recently discovered novel antibiotic, were prepared by an application of our earlier convenient synthesis of 1 and its derivatives. A 1-unsubstituted pyrazolidinone derivative bearing 2-aminothiazol-4-yl-(Z)-methoxyiminoacetyl group exhibited in vitro antibacterial activity.


Chemical & Pharmaceutical Bulletin | 1995

Optically Active Antifungal Azoles. V. Synthesis and Antifungal Activity of Stereoisomers of 3-Azolyl-2-(substituted phenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanols

Akihiro Tasaka; Norikazu Tamura; Yoshihiro Matsushita; Tomoyuki Kitazaki; Ryogo Hayashi; Kenji Okonogi; Katsumi Itoh

The (2S,3S)-, (2R,3S)- and (2S,3R)-stereoisomers of (2R,3R)-3-azolyl-2-(substituted phenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanols [(2R,3R)-1a--d] were prepared and evaluated for antifungal activity against Candida albicans in vitro and in vivo to clarify the relationships between stereochemistry and biological activities. The results revealed that the in vitro antifungal activity in each set of the four stereoisomers [(2R,3R)-, (2S,3S)-, (2R,3S)- and (2S,3R)-1a--d] definitely paralleled the in vivo antifungal activity against candidosis in mice, and the order of potency was (2R,3R) >> (2R,3S) > or = (2S,3S) > or = (2S,3R). In addition, the four stereoisomers in each set were assessed for sterol biosynthesis-inhibitory activities in C. albicans and rat liver. The (2R,3R)-isomer was found to exert a strong and selective inhibitory effect on the sterol synthesis in C. albicans as compared with that in rat liver.


The Journal of Antibiotics | 1981

SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 7β-[2-(2-AMINOTHIAZOL-4-YL)ACETAMIDO]CEPHALOSPORIN DERIVATIVES

Michihiko Ochiai; Akira Morimoto; Yoshihiro Matsushita; Taiiti Okada

In an effort to improve the antibacterial activity of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]-cephalosporins by introducing a methoxyimino group into the 7-acyl side chain, geometrically isomeric 2-(2-aminothiazol-4-yl)-2-methoxyiminoacetic acids and their derivatives were selectively synthesized. Structurally related acid derivatives were also synthesized. A facile and practical synthesis of an important starting material, 2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-methoxyiminoacetic acid, for the preparation of SCE-1365 which is now under extensive clinical trial was achieved.


Journal of The Chemical Society-perkin Transactions 1 | 1983

Synthesis of 5,6-cis-carbapenems related to C-19393 H2

Hideaki Natsugari; Yoshihiro Matsushita; Norikazu Tamura; Kouichi Yoshioka; Michihiko Ochiai

The synthesis of 6,7-cis-7-(1-hydroxy-1-methylethyl)-3-oxa-1-azabicyclo[4.2.0]octan-8-ones (3a, b), key intermediates for the preparation of the 5,6-cis-carbapenem antibiotic C-19393 H2{sodium (5R, 6R)-3-[(E)-(2-acetamidoethenyl)-(R)-sulphinyl]-6-(1-hydroxy-1-methylethyl)-7-oxo-1-azabicyclo-[3.2.0]hept-2-ene-2-carboxylate}(1a) and its derivatives, was investigated. Sulphenylation of the 3-oxa-1-azabicyclo[4.2.0]octan-8-ones (2a, b), followed by the aldol reaction with acetone, gave the 7-(1-hydroxy-1-methylethyl)-7-sulphenyl derivatives (7a—e). Reductive desulphurization of compounds (7a—e) with an organotin hydride (tri-n-butyltin hydride or triphenyltin hydride) in the presence of a radical initiator gave rise to stereoselective formation of the cis-azetidinones (3a, b). A total synthesis of (±)-C-19393 H2(1a) and its derivatives having other substituents at the C (3) position, (1b—e), starting from (3a, b)via a carbene insertion reaction, is also described.


Journal of The Chemical Society-perkin Transactions 1 | 1980

A method for the preparation of 7?-methoxycephalosporins

Akira Morimoto; Yoshihiro Matsushita; Michihiko Ochiai

A method for the preparation of 7α-methoxycephalosporins has been developed. 7β-Phosphoramidodeacetoxycephalosporin (6) and 7β-phosphoramidocephalosporin (14) obtained from the 7β-amino-derivatives (5) and (13), were converted into 7α-methoxy-7β-phosphoramidodeacetoxycephalosporin (7) and 7α-methoxy-7β-phosphoramidocephalosporin (15), respectively, by reaction with LiOMe and ButOCl. Treatment of (7) with BunLi and Et3N followed by acylation with phenylacetyl chloride gave 7α-methoxy-7β-phenylketenimino-derivative (11), which were easily hydrated to 7α-methoxy-7β-(phenylacetamido)deacetoxycephalosporin (12). Treatment of (15) under similar conditions afforded, contrary to the result obtained with (7), 7α-methoxy-7β-(phenylacetamido)cephalosporin (16), without any of the corresponding ketenimine. This method was also successfully applied to the synthesis of 6α-methoxypenicillins.


Archive | 1975

THIAZOLYLACETAMIDO CEPHALOSPORIN TYPE COMPOUNDS

Michihiko Ochiai; Taiiti Okada; Osami Aki; Akira Morimoto; Kenji Kawakita; Yoshihiro Matsushita


Archive | 1979

7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephalosporins

Michihiko Ochiai; Akira Morimoto; Yoshihiro Matsushita


Chemical & Pharmaceutical Bulletin | 1993

Optically Active Antifungal Azoles. I. Synthesis and Antifungal Activity of (2R, 3R)-2-(2, 4-Difluorophenyl)-3-mercapto-1-(1H-1, 2, 4-triazol-1-yl)-2-butanol and Its Stereoisomers

Akihiro Tasaka; Norikazu Tamura; Yoshihiro Matsushita; Katsunori Teranishi; Ryogo Hayashi; Kenji Okonogi; Katsumi Itoh

Collaboration


Dive into the Yoshihiro Matsushita's collaboration.

Top Co-Authors

Avatar

Michihiko Ochiai

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Akira Morimoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Katsumi Itoh

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tomoyuki Kitazaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Osami Aki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Norikazu Tamura

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Taiiti Okada

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Akihiro Tasaka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kenji Kawakita

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge